C/EBPβ 控制运动诱导的心脏生长,并防止病态心脏重塑
Pontus Boström1, Nina Mann, Jun Wu
1Dana-Farber Cancer Institute, Harvard Medical School, 3 Blackfan Circle, CLS Building, Floor 11, Boston, MA 02115, USA.
Cell
|December 25, 2010
概括
降低的C/EBPβ水平促进心脏生长和心肌细胞增殖,模仿运动效应. 这一发现对于理解生理性缩和开发心脏病再生疗法至关重要.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 再生医学是一种再生医学.
背景情况:
- 心脏对运动反应生理性缩的能力已经确立,但潜在的转录机制仍然不清楚.
- 成年心肌细胞的增殖对心脏再生医学具有重大前景.
- 了解影响心脏生长和再生的因素对于治疗心脏病至关重要.
研究的目的:
- 阐明参与运动诱导的生理性心脏缩的转录调节者.
- 研究特定的转录因子在心肌细胞增殖中的作用.
- 确定促进心脏再生和预防心力衰竭的新目标.
主要方法:
- 利用基于RT-PCR的综合屏幕来分析转录组件.
- 在体外和体内研究了C/EBPβ降低的影响.
- 评估心肌细胞缩和扩散,以应对改变的基因表达.
- 在基因改造小鼠中评估心脏功能和抵抗压力过载的抵抗力.
主要成果:
- 运动导致心脏中C/EBPβ的下调和CITED4表达的上调.
- 在体外和体外降低C/EBPβ模仿了运动诱导的心肌细胞缩和增殖.
- 增加CITED4表达被确定为C/EBPβ驱动的扩散的关键调解者.
- 患有心脏C/EBPβ降低的小鼠对压力过载引起的心力衰竭表现出显著的抵抗力.
结论:
- 在成年哺乳动物心脏中,C/EBPβ起到抑制心肌细胞生长和增殖的作用.
- 降低C/EBPβ是生理性缩和心肌细胞增殖中的中心信号事件.
- 准C/EBPβ可能为增强心脏修复和预防心力衰竭提供治疗策略.
相关概念视频
01:58Cell Specific Gene Expression
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
01:25cAMP-dependent Protein Kinase Pathways
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
01:26Cellular Adaptation II: Hypertrophy
Hypertrophy is the increase in the size of individual cells, resulting in the enlargement of a tissue or organ. Unlike hyperplasia, which involves an increase in cell number, hypertrophy is characterized by an increase in cell volume. This process often occurs in response to higher functional demand or hormonal stimulation, leading to the production of more structural proteins and organelles, thereby enhancing the cells' work capacity.There are two primary types of hypertrophy: physiological...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:22Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...